ALKS FY 2014 Earnings — Alkermes plc Revenue & Financial Results | Market Cap Arena

ALKSAlkermes plc

$5B

FY 2014 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$619M+7.5% YoY

Gross Profit

$443M71.6% margin

Operating Income

-$87M-14.1% margin

Net Income

-$30M-4.9% margin

EPS (Diluted)

$-0.21

Cash Flow

Operating Cash Flow

$11M

Free Cash Flow

-$23M

Stock-Based Comp.

$60M

Balance Sheet

Total Assets

$1.9B

Total Liabilities

$524M

Stockholders' Equity

$1.4B

Cash & Equivalents

$224M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$619M	$576M	+7.5%
Gross Profit	$443M	$265M	+67.1%
Operating Income	-$87M	$82M	-206.5%
Net Income	-$30M	$25M	-220.3%